Dr. John D Scandling, MD is a Nephrologist (Kidney Specialist) - General practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| Institution | Focus | Year |
|---|---|---|
| Internship - W Va University Hospital | 1979 |
| Certification | Cert. Body | Year |
|---|---|---|
| Internal medicine Sub-Specialty: Nephrology | Internal Medicine | Not Specified |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | AMERICAN JOURL OF TRANSPLANTATION | Tolerance and Withdrawal of Immunosuppressive Drugs | 2012 |
| Other Publication | CLINICAL TRANSPLANTATION | Living donor evaluation and exclusion: the Stanford experience | 2011 |
| Other Publication | AMERICAN JOURL OF KIDNEY DISEASES | United Network for Organ Sharing (UNOS) Organ Allocation Policy and Kidney Utilization | 2010 |
| Other Publication | New England jourl of medicine | Tolerance and chimerism after rel and hematopoietic-cell transplantation. | 2008 |
| Other Publication | TURE CLINICAL PRACTICE NEPHROLOGY | High rates of corory artery stenosis detected by angiography in diabetic rel transplant candidates | 2007 |
| Other Publication | CLINICAL TRANSPLANTATION | Validation of a screening protocol for identifying low-risk c | 2006 |
| Other Publication | SEMIRS IN DIALYSIS | Kidney transplant candidate evaluation | 2005 |
| Other Publication | NEPHROLOGY DIALYSIS TRANSPLANTATION | Rel juxtaglomerular apparatus hyperplasia | 2005 |
| Other Publication | TRANSPLANTATION | Dual-kidney transplantation with organs from expanded criteria donors: A long-term follow-up | 2004 |
| Other Publication | TRANSPLANTATION | Approaches to transplantation tolerance in humans | 2004 |
| Other Publication | KIDNEY INTERTIOL | A randomized, placebo-controlled trial of IGF-1 for delayed graft function | 2003 |
| Other Publication | THERAPEUTIC DRUG MONITORING | Quantification of immunosuppression by flow cytometry in stable rel transplant recipients | 2003 |
| Other Publication | PEDIATRIC TRANSPLANTATION | Increased expression of cytotoxic effector molecules | 2003 |
| Other Publication | TRANSPLANTATION | Mixed chimerism and immunosuppressive drug withdrawal after HLA | 2002 |
| Other Publication | AMERICAN JOURL OF TRANSPLANTATION | Late post-transplant anemia in adult rel transplant recipients. An under-recognized problem? | 2002 |
| Other Publication | AMERICAN JOURL OF PHYSIOLOGY-REL PHYSIOLOGY | Maintence and recovery stages of postischemic acute rel failure in humans | 2002 |
| Other Publication | Krieger, N. R., Vial, C. M., Millan, M. T., Imperial, J., Dafoe, D. C. | Revisiting the use of hepatitis B core antibody-positive donor kidneys | 2001 |
| Other Publication | AMERICAN JOURL OF PHYSIOLOGY-REL PHYSIOLOGY | PAH extraction and estimation of plasma flow in human postischemic acute rel failure | 1999 |
| Other Publication | KIDNEY INTERTIOL | Sodium reabsorption and distribution of +/K+-ATPase during postischemic injury to the rel allograft | 1999 |
| Other Publication | MOLECULAR GENETICS AND METABOLISM | Plasma glutathione peroxidase and its relationship to rel proximal tubule function | 1998 |
| Other Publication | Advances in rel replacement therapy | What is the optimal approach for the end | 1998 |
| Other Publication | TRANSPLANTATION PROCEEDINGS | Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation | 1998 |
| Other Publication | JOURL OF CLINICAL INVESTIGATION | Backleak, light junctions, and cell-cell adhesion in postischemic injury to the rel allograft | 1998 |
| Other Publication | JOURL OF SURGICAL RESEARCH | Outcome in cadaveric rel transplant recipients treated with cyclosporine A | 1998 |
| Other Publication | TRANSPLANTATION | A review of the kidneys that nobody wanted | 1998 |
| Other Publication | TRANSPLANTATION PROCEEDINGS | Expanded criteria for donor kidneys: An update on outcome in single versus dual kidney transplants | 1997 |
| Other Publication | PEDIATRIC NEPHROLOGY | Bladder augmentation can be problematic with rel failure and transplantation | 1997 |
| Other Publication | TRANSPLANTATION | Outcomes in diabetic patients after simultaneous pancreas | 1997 |
| Other Publication | TRANSPLANTATION | When should expanded criteria donor kidneys be used for single versus dual kidney transplants? | 1997 |
| Other Publication | Shen, G. K., Alfrey, E. J., Knoppel, C. L., Dafoe, D. C., Scandling, J | Eradication of cytomegalovirus reactivation disease using high-dose acyclovir | 1997 |
| Other Publication | CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | Pathophysiology of reduced glomerular filtration rate in delayed graft function | 1997 |
| Other Publication | Alfrey, E. J., Conley, S. B., Tanney, D. C., Mak, R., Scandling, J. D. | Use of an augmented uriry bladder can be catastrophic in rel transplantation | 1997 |
| Other Publication | Clinical transplants | Kidney and kidney/pancreas transplantation at Stanford University Medical Center. | 1997 |
| Other Publication | Lee, C. M., Scandling, J. D., Shen, G. K., Salvatierra, O., Dafoe, D. | The kidneys that nobody wanted - Support for the utilization of expanded criteria donors | 1996 |
| Other Publication | CLINICAL TRANSPLANTATION | THE UTILITY OF RETROPERITONEAL KIDNEY PLACEMENT IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION | 1995 |
| Other Publication | AMERICAN JOURL OF PHYSIOLOGY-REL PHYSIOLOGY | ENDOGENOUS ANP IN POSTISCHEMIC ACUTE REL-ALLOGRAFT FAILURE | 1995 |
| Other Publication | CLINICAL TRANSPLANTATION | CLINICAL OUTCOME OF INTERVAL CADAVERIC REL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS | 1995 |
| Other Publication | TRANSPLANTATION | THE USE OF SPIRAL COMPUTED-TOMOGRAPHY IN THE EVALUATION OF LIVING DONORS FOR KIDNEY-TRANSPLANTATION | 1995 |
| Other Publication | JOURL OF CLINICAL INVESTIGATION | MECHANISMS OF FILTRATION FAILURE DURING POSTISCHEMIC INJURY OF THE HUMAN KIDNEY | 1995 |
| Other Publication | TRANSPLANTATION | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND EPSTEIN-BARR-VIRUS PROPHYLAXIS | 1995 |
| Other Publication | TRANSPLANTATION | ENDOVASCULAR STENTING OF THE ABDOMIL-AORTA FOLLOWING REL-TRANSPLANTATION | 1994 |
| Other Publication | TRANSPLANTATION | SPIRAL COMPUTED-TOMOGRAPHY IN THE DIAGNOSIS OF TRANSPLANT REL-ARTERY STENOSIS | 1994 |
| Other Publication | KIDNEY INTERTIOL | GLOMERULAR SIZE-SELECTIVITY AND MICROALBUMINURIA IN EARLY DIABETIC GLOMERULAR-DISEASE | 1992 |
| Other Publication | DIABETES | ATRIAL-TRIURETIC-PEPTIDE AND RESPONSE TO CHANGING PLASMA-VOLUME IN DIABETIC NEPHROPATHY | 1991 |
| Other Publication | AMERICAN JOURL OF PHYSIOLOGY | MECHANISM OF POTASSIUM-DEPLETION DURING CHRONIC METABOLIC-ACIDOSIS IN THE RAT | 1987 |
Dr. John D Scandling, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 39 (started in 1985)
Accepts New Patients: Yes
Dr. John D Scandling, MD has not yet listed the medications that he commonly prescribes.
Dr. John D Scandling, MD has not yet added any information about his practice's billing policies and payment options.
